Merck Serono to Expand Research and Development Presence in China
China's Research and Development Organization Will Become the Fourth Key R&D Hub for Merck Serono Worldwide
Merck Serono, a division of Merck KGaA, announced plans to strengthen its global research and development (R&D) capabilities by establishing a global R&D center in Beijing, China. Merck Serono is planning to invest more than150 Million EURand create more than 200 new qualified jobs over the next four years to set up the China R&D center and conduct R&D activities inChina.
"The creation of the China R&D center marks a new milestone in Merck Serono&'s commitment to China, where there is a rising demand for more healthcare options," said Elmar Schnee, President of Merck Serono. "We are committed to investing in areas that can helpChinato address some of its public health needs that currently are not met."
"China is a country with talented scientists and high-quality research," added Bernhard Kirschbaum, Executive Vice President, Research and Development for Merck Serono. "We will recruit more R&D talent in China and build a world-class organization in China that will extend our global R&D expertise and capabilities."
The China R&D organization will become one of the key R&D hubs for Merck Serono worldwide. Key hubs so far are Germany, Switzerland and the United States.
The Chinat eam will lead drug development for China and other Asian countries, for local clinical trials as well as for the participation in global clinical trials. The team also will ensure the management of collaborations with research institutions inChinaand continue to look for partnerships with local academic institutions and companies. Research activities conducted in the China R&D center will mainly focus on biomarker research including pharmacogenomics and bioanalytics activities.
Merck Serono already has some research collaborations in China and plans to further develop its collaboration network and build its R&D strategy on more innovation opportunities by tapping into the Chinese scientific expertise.
Topics
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.